N
Nkarta, Inc.
NKTXHealth Care· South San Francisco, California, United States
LAYOFFS TRACKED
1
LAST EVENT
Mar 31, 2025
MARKET CAP
$188.37M
as of Aug 26, 2026
EMPLOYEES
165
Nkarta, Inc. is a clinical-stage cell therapy company focused on developing allogeneic (off-the-shelf) natural killer (NK) cell therapies for patients with hematologic malignancies and solid tumors. The company engineers NK cells to enhance potency, persistence, and tumor targeting with the goal of delivering scalable, off-the-shelf cancer treatments.
Layoff timeline
1 EVENTMar 31, 2025WARN notice
Layoff at Nkarta, Inc. · ~53 roles
Shoreline Court South San Francisco, CA · 2 locations
Stories from here
No one has shared a story from Nkarta yet. Went through a layoff here? Your experience helps others feel less alone.
Share your story →Get alerts for Nkarta
We'll email you the moment a new layoff is reported here.